𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck

✍ Scribed by Nikolina Vlatković; Ashraf El-Fert; Timothy Devling; Arpita Ray-Sinha; David M. Gore; Carlos P. Rubbi; Andy Dodson; Andrew S. Jones; Tim R. Helliwell; Terence M. Jones; Mark T. Boyd

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
590 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND:

Recent genetic studies have implicated p53 mutation as a significant risk factor for therapeutic failure in squamous cell carcinoma of the head and neck (SCCHN). However, in a recent meta‐analysis in the literature of p53 from major anatomical subsites (larynx, oral cavity, oropharynx/hypopharynx), associations between patient survival and p53 status were ambiguous.

METHODS:

The authors examined a cohort of SCCHNs using a previously developed biomarker combination that likely predicts p53 status based on p53/MDM2 expression levels determined by immunohistochemistry (IHC). In addition, the authors generated and validated an antibody to MTBP (an MDM2 binding protein that alters p53/MDM2 homeostasis and may contribute to metastatic suppression) and have incorporated data for MTBP expression into the current analyses.

RESULTS:

Analysis of expression data for p53 and MDM2 in 198 SCCHN patient samples revealed that the biomarker combination p53 + ve/MDM2‐low (likely indicative of p53 mutation) was significantly associated with reduced overall survival (log‐rank P = .035) and was an independent prognostic factor (P = .013; HR, 1.705; 95% CI, 1.12‐2.60); thus, these data were compatible with earlier genetic analyses. By using IHC for p53 and MDM2 to dichotomize patients, the authors found that loss of MTBP expression was significantly associated with reduced survival (log‐rank P = .004) and was an independent prognostic factor (P = .004; HR, 2.78; 95% CI, 1.39‐5.54) in p53 + ve/MDM2‐low patients.

CONCLUSIONS:

These results represent the first examination of MTBP expression in human tissues and provide evidence for a p53 status‐dependent role for MTBP in suppressing disease progression in SCCHN patients as well as confirming a role for p53 pathway function in delaying disease progression. Cancer 2011. © 2011 American Cancer Society.

📜 SIMILAR VOLUMES

Loss of 18q predicts poor survival of pa
Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck
✍ Richard P. Pearlstein; Michael S. Benninger; Thomas E. Carey; Richard J. Zarbo; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Tumor suppressor genes play an important role in normal growth regulation. Loss or inactivation of these genes has been implicated in the development of squamous cell cancer and progression of neoplasia. Previous studies in our laboratories have implicated chromosome 18 long-arm deletions as a possi

High serum levels of YKL-40 in patients
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival
✍ Anne Roslind; Julia S. Johansen; Ib J. Christensen; Katalin Kiss; Eva Balslev; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 2 views

## Abstract YKL‐40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. Elevated serum levels of YKL‐40 are associated with poor prognosis in several malignancies. In this study, we examined the prognostic value of serum YKL‐40 before treatment and during follow‐up in p

Using TNM staging to predict survival in
Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck
✍ Stephen F. Hall; Patti A. Groome; Deanna Rothwell; Peter F. Dixon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

## Background: There is a need for a classification system for prognosis based on the tnm system for patients with squamous cell carcinoma of the head and neck such that patient groupings are homogeneous within and heterogeneous between. ## Methods: Six hundred fifty-five consecutive patients wit

Loss of distal 11q is associated with DN
Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma
✍ Rahul A. Parikh; Jason S. White; Xin Huang; David W. Schoppy; Bora E. Baysal; Ra 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

## Abstract About 45% of head and neck squamous cell carcinomas (HNSCC) are characterized by amplification of chromosomal band 11q13. This amplification occurs by a breakage‐fusion‐bridge (BFB) cycle mechanism. The first step in the BFB cycle involves breakage and loss of distal 11q, from __FRA11F_